3 assets in Auditory Perceptual Disorders

Therapeutic assets addressing Auditory Perceptual Disorders, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Hyoscine Auditory Perceptual Disorders	Yale University	Early P1	C (39)
Rivastigmine Auditory Perceptual Disorders	Yale University	Early P1	C (39)
Risperidone Auditory Perceptual Disorders	Hasanuddin University	N/A	NR ()